Trial Drug From Saliva Of Lizard Controls Blood Sugar And Weight

A new type 2 diabetes drug derived from the saliva of a huge, venomous lizard may control blood sugar without the weight gain associated with other diabetes medications. The trial drug, which has not yet won approval from the U.S. Food and Drug Administration, "will mean a new method, a novel treatment for type 2 diabetes patients, the likes of which we have not seen before," said Dr. Dennis Kim, director of clinical affairs for Amylin Pharmaceuticals in San Diego, which funded the study and makes the medication. The findings were presented June 5 at the annual meeting of the American Diabetes Association in Orlando, Fla.

Back to news